Copyright
©The Author(s) 2025.
World J Exp Med. Mar 20, 2025; 15(1): 96988
Published online Mar 20, 2025. doi: 10.5493/wjem.v15.i1.96988
Published online Mar 20, 2025. doi: 10.5493/wjem.v15.i1.96988
Table 1 Sample characteristics, n (%)/mean ± SD/ median (minimum-maximum)
| Variables | Total (n = 208) | Stage I (n = 25) | Stage II (n = 51) | Stage III + IV (n = 132) | P value |
| Demographics | |||||
| Age (years) (n = 208) | 48.5 ± 10.25 | 44.8 ± 9.08 | 49.52 ± 10.80 | 48.80 ± 10.15 | 0.14a |
| > 40 tahun | 41 (19.6) | 18 (72.00) | 40 (78.4) | 109 (82.6) | 0.44c |
| 18-40 tahun | 167 (79.9) | 7 (28.00) | 11 (21.60) | 23 (17.4) | |
| Marital status (n = 203) | 0.41c | ||||
| Married | 200 (98.5) | 24 (100) | 51 (100) | 125 (97.7) | |
| Not married | 3 (1.5) | 0 | 0 | 3 (2.3) | |
| Parity history (n = 199) | 0.34c | ||||
| Multiparity and grand multiparity | 175 (87.90) | 23 (95.8) | 42 (84.00) | 110 (88.00) | |
| Nulliparity dan primiparity | 24 (12.10) | 1 (4.2) | 8 (16.00) | 15 (12.00) | |
| Hormonal contraception use (n = 173) | 0.39c | ||||
| Yes | 5 (2.90) | 1 (4.3) | 0 | 4 (3.8) | |
| No | 168 (97.10) | 22 (95.7) | 46 (100) | 168 (97.10) | |
| Histolopathological classification | |||||
| Histopathological findings (n = 175) | 0.33c | ||||
| Squamous cell carcinoma | 120 (68.60) | 13 (59.10) | 28 (63.60) | 79 (72.5) | |
| Adenocarcinoma, mixed, and other | 55 (31.40) | 9 (40.9) | 16 (36.4) | 30 (27.5) | |
| Laboratory examinations | |||||
| Haemoglobin (g/L) (n = 204) | 102.5 ± 24.7 | 124.6 ± 11.4 | 109.3 ± 21.2 | 95.4 ± 24.6 | < 0.001a |
| Leucocyte (× 109/L) (n = 204) | 9.85 (4.05-29.60) | 7.47 (5.15-13.56) | 8.84 (4.32-22.34) | 11.08 (4.05-29.60) | < 0.001b |
| Neutrophil (× 109/L) (n = 186) | 6.50 (1.52-25.16) | 4.78 (2.66-8.90) | 5.69 (3.14-17.20) | 7.43 (1.52-25.16) | < 0.001b |
| Monocyte (× 109/L) (n = 186) | 0.65 (0.18-2.10) | 0.55 (0.33-1.22) | 0.53 (0.18-1.55) | 0.69 (0.27-2.10) | 0.002b |
| Lymphocyte (× 109/L) (n = 186) | 2.19 ± 2.15 | 2.18 ± 0.56 | 2.47 ± 0.72 | 2.09 ± 0.76 | 0.006a |
| Thrombocyte (× 109/L) (Neutrophil (× 109/L) (n = 186) | 375.5 (99-1143) | 307.00 (99.00-446.00) | 364.00 (131.00-1143.00) | 397.00 (147.00-791.00) | < 0.001b |
| Neutrophil lymphocyte ratio (n = 186) | 3.13 (0.60-31.33) | 2.37 (0.96-4.22) | 2.31 (1.02-7.55) | 3.78 (0.60-31.33) | < 0.001b |
| Lymphocyte monocyte ratio (n = 186) | 3.29 (0.67-13.50) | 3.77 ± 0.94 | 4.21 (1.86-13.50) | 3.00 (0.67-8.25) | < 0.001b |
| Platelet lymphocyte ratio (n = 186) | 176.01 (63.82-779.08) | 141.03 (77.67-232.27) | 138.96 (70.91-561.12) | 200.49 (63.82-779.08) | < 0.001b |
| Systematic inflammation index (n = 186) | 1195.47 (160.20-12282.67) | 719.00 ± 309.59 | 1159.36 (308.71-5715.00) | 1609.14 (160.20-12282.67) | < 0.001b |
| Systematic inflammatory response index (n = 186) | 1.99 (0.25-16.54) | 1.51 ± 0.80 | 1.17 (0.40-6.88) | 2.96 (0.25-16.54) | < 0.001b |
- Citation: Liana P, Syahbiran HG, Sari NP, Rahadiyanto KY, Nurwany R, Nurhidayat W, Umar TP. Haematology results, inflammatory haematological ratios, and inflammatory indices in cervical cancer: How is the difference between cancer stage? World J Exp Med 2025; 15(1): 96988
- URL: https://www.wjgnet.com/2220-315x/full/v15/i1/96988.htm
- DOI: https://dx.doi.org/10.5493/wjem.v15.i1.96988